Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
We report a case of systemic sclerosis with interstitial pneumonia and severe pulmonary hypertension treated with bosentan, an endothelin receptor antagonist. Within a short period of administration of the bosentan the skin sclerosis improved.